Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,350 | 1 | 43.2% |
| Unspecified | $2,323 | 2 | 42.7% |
| Travel and Lodging | $648.05 | 5 | 11.9% |
| Food and Beverage | $124.97 | 3 | 2.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $3,123 | 9 | $0 (2018) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $2,323 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $3,123 | 9 | Eisai Inc. ($3,123) |
| 2017 | $2,323 | 2 | NOVARTIS PHARMACEUTICALS CORPORATION ($2,323) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,350.00 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $524.61 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $67.34 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $49.99 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $49.99 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $18.30 | General |
| Category: Oncology | ||||||
| 04/27/2018 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $17.80 | General |
| Category: Oncology | ||||||
| 12/23/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | FARYDAK (Drug) | — | In-kind items and services | $1,713.64 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY | ||||||
| 05/04/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | FARYDAK (Drug) | — | In-kind items and services | $609.36 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: HEMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $2,323 | 2 |
About James Talcott, MDSM
James Talcott, MDSM is a Medical Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871580761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Talcott, MDSM has received a total of $5,446 in payments from pharmaceutical and medical device companies, with $3,123 received in 2018. These payments were reported across 11 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($2,350).
Practice Information
- Specialty Medical Oncology
- Location New York, NY
- Active Since 10/05/2005
- Last Updated 10/12/2015
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1871580761
Products in Payments
- Lenvima (Drug) $3,123
- FARYDAK (Drug) $2,323
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in New York
Craig Thompson, Md, MD
Medical Oncology — Payments: $2.1M
Andrew Seidman, Md, MD
Medical Oncology — Payments: $1.7M
Dr. Joshua Richter, M.d, M.D
Medical Oncology — Payments: $1.6M
Ghassan Abou-Alfa, Md, MD
Medical Oncology — Payments: $1.2M
Edward Gelmann
Medical Oncology — Payments: $944,679
Miguel Perales, Md, MD
Medical Oncology — Payments: $759,555